Alpha Cognition Past Earnings Performance
Past criteria checks 0/6
Alpha Cognition's earnings have been declining at an average annual rate of -7.6%, while the Biotechs industry saw earnings growing at 13.8% annually.
Key information
-7.6%
Earnings growth rate
12.5%
EPS growth rate
| Biotechs Industry Growth | 51.1% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Alpha Cognition makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | -14 | 5 | 5 |
| 30 Sep 23 | 0 | -12 | 4 | 6 |
| 30 Jun 23 | 0 | -11 | 4 | 6 |
| 31 Mar 23 | 0 | -11 | 4 | 8 |
| 31 Dec 22 | 0 | -12 | 4 | 9 |
| 30 Sep 22 | 0 | -11 | 5 | 9 |
| 30 Jun 22 | 0 | -13 | 4 | 10 |
| 31 Mar 22 | 0 | -10 | 4 | 8 |
| 31 Dec 21 | 0 | -20 | 3 | 8 |
| 30 Sep 21 | 0 | -18 | 2 | 7 |
| 30 Jun 21 | 0 | -15 | 2 | 5 |
| 31 Mar 21 | 0 | -17 | 1 | 5 |
| 31 Dec 20 | 0 | -6 | 1 | 5 |
| 30 Sep 20 | 0 | -6 | 1 | 5 |
Quality Earnings: ACOG is currently unprofitable.
Growing Profit Margin: ACOG is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ACOG is unprofitable, and losses have increased over the past 5 years at a rate of 7.6% per year.
Accelerating Growth: Unable to compare ACOG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ACOG is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-14%).
Return on Equity
High ROE: ACOG's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.